Does percutaneous nephrolithotomy in children cause significant renal scarring?
Abstract
Objective
To determine the frequency of renal parenchymal damage following percutaneous nephrolithotomy (PCNL) in children.
Patients and methods
Fifty-six children undergoing PCNL in 60 renal units between January 2000 and December 2004 were included in this prospective study, and were subjected to postoperative technetium-99m dimercaptosuccinic acid (99mTc-DMSA). Using a standard questionnaire, demographics, number, size and location of stones, procedure details, outcome as indicated by clearance with PCNL alone or additional procedures, and follow up were documented. Presence of focal renal damage and its association with the PCNL tract were examined.
Results
Out of 60 renal units, cortical defects on 99mTc-DMSA scan were seen in 10 renal units (17%). In three of these kidneys, the site of focal defect corresponded to the access site for tract formation during PCNL. Two additional kidneys had scarring at multiple sites, one of which corresponded to the access site during PCNL. In the remaining five kidneys no association between focal renal damage and nephrostomy tract site could be ascertained. No association was seen between renal damage and the size of nephroscope used during PCNL.
Conclusion
There exists a risk of focal damage to renal parenchyma from the formation of the nephrostomy tract. In our series, focal damage was seen in 5% of patients; this may be an overestimate since preoperative 99mTc-DMSA scans were not available for our patients. Meticulous technique is important combined with a smaller nephroscope to minimize renal damage. Long-term follow up of such children is required to assess how many are left with permanent renal scars.
Keywords: Percutaneous nephrolithotomy, 99mTc-DMSA, Focal renal damage, Renal calculi
To access this article, please choose from the options below
PII: S1477-5131(06)00033-7
doi:10.1016/j.jpurol.2006.02.001
© 2006 Journal of Pediatric Urology Company. Published by Elsevier Inc. All rights reserved.
